Vedolizumab for pediatric patients with gastrointestinal acute graft-versus-host-disease.

导出原文传递

翻译打印收藏纠错

第一作者： Gefen,Aldouby Bier

第一单位： Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.;Faculty of Medicine, Pharmacy Division, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.

作者： Gefen,Aldouby Bier ^[1] ; Irina,Zaidman ^[2] ; Yael,Dinur Schejter ^[2] ; Adeeb,NaserEddin ^[2] ; Polina,Stepensky ^[2] ; Ehud,Even-Or ^[2]

作者单位： Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel.;Faculty of Medicine, Pharmacy Division, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. ^[1] Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, Israel. ^[2]

关键词 gastrointestinal GVHD pediatric stem cell transplantation vedolizumab

主题词人类(Humans);儿童(Child);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);甾类(Steroids);急性病(Acute Disease)

DOI 10.1002/pbc.30061

PMID 36326084

发布时间 2022-12-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交